Clinical Trial Update: Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a combination chemotherapy regimen for young patients with relapsed or refractory leukemia has completed enrollment and reported result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia | Phase 1 | Status: COMPLETED